Ms. Mangrum is a partner with 30 years of litigation experience. Her practice has been focused almost exclusively on the defense of pharmaceutical and medical device manufacturers in products liability and commercial litigation.

Ms. Mangrum has litigated product liability cases in state and federal trial and appellate courts throughout the United States. In the area of pharmaceutical and medical device products liability litigation, Ms. Mangrum has defended manufacturers of many different products, including synthetic and natural hormone therapies, antidepressants, anxiolytics, sleeping pills, chemotherapeutic agents, anticoagulants, over-the-counter cough/cold medications and a variety of contraceptive methods.

While in law school, she served on the editorial board of the Missouri Law Review and was a member of Order of the Coif. In 2015, she was selected as a national member of the Order of the Barristers.

Product Liability Litigation - Ms. Mangrum served as national counsel for Eli Lilly and Company in litigation concerning Lilly's neuroscience products Prozac®, Strattera® and Cymbalta®. Ms. Mangrum also acted as Bayer Corporation's national coordinating counsel in state and federal litigation in which plaintiffs alleged that Bayer's PPA-containing products caused hemorrhagic and ischemic strokes. Ms. Mangrum was a member of key litigation and trial teams in Yasmin®/YAZ® and Mirena® product liability litigation.

Commercial - Ms. Mangrum has participated in the arbitration of alleged breaches of co-marketing and licensing agreements related to pharmaceutical products. She has also worked on the defense of an antitrust case brought by a generic manufacturer against a name-brand manufacturer.